Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELVITEGRAVIR, with a corresponding US DMF Number 27727.
Remarkably, this DMF maintains an Active status since its submission on December 27, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 31, 2014, and payment made on December 09, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II